Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$136,847,094
+$45,590,260 QoQ
Shares Held
306,461
+52.2% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. VRTX ranks #3 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,847,094 | 306,461 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $91,256,834 | 201,290 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $73,691,374 | 188,161 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $128,169,518 | 287,892 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $70,205,814 | 144,808 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,634,922 | 192,786 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $267,435,882 | 575,032 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $95,309,993 | 203,341 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $96,642,657 | 231,197 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $298,997,013 | 734,835 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $277,623,792 | 798,366 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $102,045,806 | 289,977 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $104,850,885 | 332,786 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $101,064,625 | 349,971 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $104,492,669 | 360,892 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $290,083,643 | 1,029,432 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $115,038,707 | 440,812 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $114,505,369 | 521,427 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $89,002,812 | 490,671 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $80,513,681 | 399,314 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $83,287,066 | 387,580 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $95,485,850 | 404,019 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $225,795,107 | 829,763 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $235,747,687 | 812,055 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $117,885,664 | 495,422 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||